News
Sermonix to Present Poster at ENDO 2019 on Lasofoxifene’s ‘Potent Anti-Tumor Activity’ in ESR1 Hormone-Resistant Breast Cancer
Biopharmaceutical company collaborated with Ben May Department for Cancer Research at University...
To sign up for future Sermonix press releases, please enter your information below.